Roger Pomerantz, President and CEO at Seres Therapeutics, Inc. (MCRB), sold 26,056 shares at $9.15 ($238K) on 2018-06-28, disclosed to the SEC on 2018-06-29.
Open-market sale of $238k MCRB by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.15 | 21,560 | $197K | 82.8% |
| 2 | $9.10 | 4,496 | $41K | 17.2% |
| Total | $9.14 avg | 26,056 | $238K | 100% |
| Filing → |
| RUBY | BUY | 2018-07-23 | $2K | — | Filing → |
| MCRB | SELL | 2018-07-12 | $9K | — | Filing → |
| MCRB | SELL | 2018-07-10 | $590K | — | Filing → |